{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:53:25Z","timestamp":1792004005423,"version":"4.4.0"},"reference-count":120,"publisher":"Informa UK Limited","issue":"18","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2025,12,12]]},"DOI":"10.1080\/14656566.2025.2608081","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:33:18Z","timestamp":1766161998000},"page":"1985-1996","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Recalcitrant dermatophytosis: clinicomycological features and challenges in management"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8664-7723","authenticated-orcid":false,"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"University of Toronto","place":["Toronto, Canada"]},{"name":"Mediprobe Research Inc","place":["London, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9359-9750","authenticated-orcid":false,"given":"Tong","family":"Wang","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc","place":["London, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6079-4517","authenticated-orcid":false,"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[{"name":"University of Toronto","place":["Toronto, Canada"]},{"name":"Women\u2019s College Hospital","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy776"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13191"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2022.101115"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.4103\/cdr.cdr_29_24"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07430.x"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00960-9"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20146"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljaf269"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20210570"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_297_16"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12503"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12895-018-0073-1"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_233_20"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llae042"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy099"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14799"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19420"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2023.101432"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2801.210810"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.70049"},{"key":"e_1_3_4_23_1","first-page":"1","article-title":"Case of terbinafine-resistant tinea cruris caused by Trichophyton tonsurans","volume":"2021","author":"Firooz A","year":"2021","unstructured":"Firooz A, Lotfali E, Fattahi M, et al. Case of terbinafine-resistant tinea cruris caused by Trichophyton tonsurans. Case Rep Dermatol Med. 2021;2021:1\u20133.","journal-title":"Case Rep Dermatol Med"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.101087"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.70049"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.05.025"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106677"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15793"},{"key":"e_1_3_4_29_1","first-page":"107","article-title":"A case of altered clinical picture of extensive tinea corporis (Tinea as a great mimicker)","volume":"22","author":"Henry D","year":"2019","unstructured":"Henry D, Singh A, Madke B, et al. A case of altered clinical picture of extensive tinea corporis (Tinea as a great mimicker). Iran J Dermatol. 2019;22:107\u2013109.","journal-title":"Iran J Dermatol"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2019.100903"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.33235\/rsaj.15.3.92-96"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20439"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2801.210883"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02393-21"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2022.101306"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15300"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15900"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.563"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.24-0027"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mmcr.2023.08.004"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17463"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.15570\/actaapa.2024.4"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/12034754221077891"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_483_19"},{"key":"e_1_3_4_45_1","first-page":"91(6):807","article-title":"Multi drug failure of tinea corporis to terbinafine, itraconazole and fluconazole; translating extensive Indian microbiological and resistance data to a trial of ketoconazole with remarkable efficacy","author":"Sharath S","year":"2024","unstructured":"Sharath S, Sardana K, Khurana A. Multi drug failure of tinea corporis to terbinafine, itraconazole and fluconazole; translating extensive Indian microbiological and resistance data to a trial of ketoconazole with remarkable efficacy. Indian J Dermatol Venereol Leprol. 2024;91(6):807\u2013809.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00234-24"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17501"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof9111122"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19404"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19594"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm2409010"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_807_17"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13360"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30338-4"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_728_19"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.11721"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1580221"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.3.5611.149"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.15254"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1086\/338023"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30079-3"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.17966\/kjmm.2012.17.1.1"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-024-01065-5"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.4103\/CDR.CDR_39_17"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208487"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.ijd_832_23"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.03.024"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01038-18"},{"key":"e_1_3_4_69_1","first-page":"91(6):846","article-title":"Trichophyton indotineae and itraconazole failures: is it really happening and what can we do about it?","author":"Sardana K","year":"2025","unstructured":"Sardana K, Sharath S, Khurana A. Trichophyton indotineae and itraconazole failures: is it really happening and what can we do about it? Indian J Dermatol Venereol Leprol. 2025;91(6):846\u2013847.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.70101"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70483-9"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijdd.ijdd_20_17"},{"key":"e_1_3_4_73_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for SPORANOX (itraconazole) capsules [Internet]. 2024 [cited 2025 Nov 4]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/020083s070lbl.pdf"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2024.10.003"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13367"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.ijd_831_23"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.ijd_991_21"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1708848"},{"key":"e_1_3_4_79_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for TOLSURA (itraconazole capsules) [Internet]. 2024 [cited 2025 Oct 27]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/208901s004lbl.pdf"},{"key":"e_1_3_4_80_1","unstructured":"Therapeutic Goods Administration. Australian product information for LOZANOC (itraconazole capules) [Internet]. 2024 [cited 2025 Oct 27]. Available from: https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent=&id=CP-2014-PI-01749-1&d=20251027172310101"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.idoj_668_22"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1675857"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00321-21"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00933-23"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01535-24"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05418.x"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(02)80040-6"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1920.02350060067010"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof7080663"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1994.tb01524.x"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.14666"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S84765"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1968.tb28546.x"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn245"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.3390\/biology14081016"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20810"},{"key":"e_1_3_4_97_1","unstructured":"U.S. Food And Drug Administration. Prescribing information for VFEND (voriconazole) tablets [Internet]. 2025 [cited 2025 Nov 3]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/021266s057 021267s067 021630s047lbl.pdf"},{"key":"e_1_3_4_98_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for NOXAFIL (posaconazole) injection delayed-release tablets oral suspension delayed-release oral suspension [Internet]. 2024 [cited 2025 Nov 4]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/022003s033 205053s017 205596s020 214770s008lbl.pdf"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.6.1208"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475415574970"},{"key":"e_1_3_4_101_1","unstructured":"U.S. Food and Drug Administration. FDA drug safety communication: FDA warns that prescribing of nizoral (ketoconazole) oral tablets for unapproved uses including skin and nail infections continues; linked to patient death [Internet]. 2016 [cited 2025 Oct 28]. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-prescribing-nizoral-ketoconazole-oral-tablets-unapproved"},{"key":"e_1_3_4_102_1","unstructured":"Health Canada. KETOCONAZOLE - Risk of potentially fatal liver toxicity - for health professionals [Internet]. 2013 [cited 2025 Oct 28]. Available from: https:\/\/recalls-rappels.canada.ca\/en\/alert-recall\/ketoconazole-risk-potentially-fatal-liver-toxicity-health-professionals"},{"key":"e_1_3_4_103_1","unstructured":"Health Sciences Authority. Safety advisory on oral ketoconazole [Internet]. 2014 [cited 2025 Oct 28]. Available from: https:\/\/www.hsa.gov.sg\/announcements\/safety-alert\/safety-advisory-on-oral-ketoconazole"},{"key":"e_1_3_4_104_1","unstructured":"European Medicines Agency. European medicines agency recommends suspension of marketing authorisations for oral ketoconazole [Internet]. 2013 [cited 2025 Oct 28]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/european-medicines-agency-recommends-suspension-marketing-authorisations-oral-ketoconazole"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.21-0505"},{"key":"e_1_3_4_106_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for NAFTIN (naftifine) cream 2% [Internet]. [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/019356s008 019599s014 204286s003lbl.pdf"},{"key":"e_1_3_4_107_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for LAMISIL (terbinafine hydrochloride solution 1%). [Internet]. 2003 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2003\/20749slr004_lamisil_lbl.pdf"},{"key":"e_1_3_4_108_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for LAMISIL (terbinafine) DermGel 1% [Internet]. 1999 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/1999\/20846s001lbl.pdf"},{"key":"e_1_3_4_109_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for MENTAX-TC (butenafine HCl) cream 1% [Internet]. 2002 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2002\/21408lbl.pdf"},{"key":"e_1_3_4_110_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for CLOTIC (clotrimazole) otic solution [Internet]. 2025 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/217628s000lbl.pdf"},{"key":"e_1_3_4_111_1","unstructured":"U.S. Food and Drug Administration. Prescribing information of OXISTAT (oxiconazole nitrate cream) 1% [Internet]. 2004 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/19828slr009 20209slr005_oxistat_lbl.pdf"},{"key":"e_1_3_4_112_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for ECOZA (econazole nitrate) topical foam [Internet]. 2019 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/205175s003lbl.pdf"},{"key":"e_1_3_4_113_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for EXTINA (ketoconazole) foam 2% [Internet]. 2018. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021738s007lbl.pdf"},{"key":"e_1_3_4_114_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for NIZORAL (ketoconazole) 2% shampoo [Internet]. 2013 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/019927s032lbl.pdf"},{"key":"e_1_3_4_115_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for LUZU (luliconazole) cream 1% [Internet]. 2017 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/204153s004s005lbl.pdf"},{"key":"e_1_3_4_116_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for ERTACZO (sertaconazole nitrate) cream [Internet]. 2020 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/021385s006lbl.pdf"},{"key":"e_1_3_4_117_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for LOPROX (ciclopirox) cream 0.77% [Internet]. 2013 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/018748s024 019824s023 020519s016lbl.pdf"},{"key":"e_1_3_4_118_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for penlac nail lacquer (ciclopirox) 8% [Internet]. 2004 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/21022s004lbl.pdf"},{"key":"e_1_3_4_119_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for LAMISIL (terbinafine hydrochloride) tablets [Internet]. 2019 [cited 2025 Oct 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020539s033lbl.pdf"},{"key":"e_1_3_4_120_1","unstructured":"U.S. Food and Drug Administration. Prescribing informatio of DIFLUCAN (fluconazole) tablets and oral solution [Internet]. 2024. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/019949s072lbl.pdf"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-024-00848-1"},{"key":"e_1_3_4_122_1","unstructured":"U.S. Food and Drug Administration. Prescribing information for LAMISIL (terbinafine hydrochloride) oral granules [Internet]. 2019 [cited 2025 Dec 12]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/022071s015lbl.pdf"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2025.2608081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:12:03Z","timestamp":1770271923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2025.2608081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":120,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,12,12]]}},"alternative-id":["10.1080\/14656566.2025.2608081"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2025.2608081","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}